CClinicalTrials.gg
CompletedNCT02161445STA/AHFUpdated Jul 1, 2020

Systolic Time Intervals in the Diagnosis of Heart Failure in Emergency Departement

An observational study in Dyspnea, sponsored by University of Monastir. Completed at 1 site in Tunisia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-07-01.

Sponsored by University of Monastir · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
530
Ages
18 Years and older
Sex
All
01

Study summary

the gold standard for the diagnostic of acute heart failure is based on clinical, biological (BNP levels) and echocardiographic findings, but still in some cases, the diagnosis is difficult and requires further investigations.

BNP dosages and echocardiography are not always available in many medical centers, especially in emergency departements, and are expensive.

we investigated the use of alternative methods, such as the systolic time intervals (STI), in the diagnosis of acute heart failure (AHF) in emergency departement patients consulting for dyspnea.

Read the detailed description

AHF is a common cause for dyspnea, but still hard to diagnose. in emergency departements, physicians dispose of a variety of techniques helping them to identify patients with acute onset dyspnea due to cardiac causes and allowing them to initiate the appropriate therapeutics.

techniques such as the N type brain natriuretic peptid (NT BNP) dosages and echocardiography, in addition to the clinical exam, are efficient in these cases but they encounter many problems:

  • the BNP dosages are non-conclusive in some cases (grey zone) and must be repeated wich takes time.
  • echocardiography is operator - dependent technique and could be misleading in some conditions.
  • both BNP and echocardiography are expensive and not found in many emergency structures, especially in poor countries.

all the arguments pushed us to investigate other simpler and cheaper techniques to apply in these conditions.

STI is an old technique based on the recording of two parameters: electrocardiogram and phonocardiogram, and from them measuring the different systolic intervals:

  • pre-ejection period (PEP): defined as the interval between the beginning of the QRS wave and the first heart sound (B1).
  • electro-mechanic activation time (EMAT): defined as the interval between the two heart sounds B1 and B2
  • the PEP / EMAT time in acute onset heart failure, the conduction times are increased, due to tissular lesions, which prolong the PEP, also the myocardial contractility is deficient and the heart puts less time to eject the blood volume which decrease the EMAT and in summary the PEP/EMAT is increased significatively.

in this study protocol, we aimed to investigate the diagnostic performance of STI compared to conventional methods in the diagnosis of acute heart failure in emergency department settings.

02

Conditions studied

  • Dyspnea

Keywords

  • impedance
  • pep
  • tevg
  • dyspnea
  • AHF
  • BNP
03

In context

Dyspnea

656 studies on the registry are indexed under Dyspnea; 153 are open to participants now.

This study's enrollment of 530 is above the median of 122 across 204 observational studies indexed under Dyspnea.

Browse Dyspnea studies →

Lead sponsor

University of Monastir is the lead sponsor of 112 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

All patients aged more than 18 years old presenting at the ED with non traumatic dyspnea.

Inclusion criteria

  • non traumatic dyspnea
  • age more than 18 years old.

Exclusion criteria

Exclusion Criteria:

  • ECG diagnostic for acute myocardial infarction or ischemic chest pain within the prior 24 hours
  • history of a heart transplant
  • pericardial effusion
  • chest wall deformity suspected of causing dyspnea
  • coma, shock,Mechanical Ventilation, vasopressor drugs
  • arrhythmia serious and sustained, pace maker severe mitral valve disease, severe pulmonary arterial hypertension
  • renal failure with creatinine >350micromol/l
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
530 participants (actual)
Patient registry
No

Groups and cohorts

  • AHF group

    patients with AHF diagnosed based on clinical, biological and echocardiographic findings. Two sub-groups of patients were identified within HF group: Patients with reduced (\<45%) LVEF (HFrEF) and those with preserved (≥45%) LVEF (HFpEF).

    Device: the acoustic cardiographic parameters were calculated

  • non AHF group

    we included patients with acute dyspnea and for whom acute heart failure was excluded

    Device: the acoustic cardiographic parameters were calculated

Interventions

  • Devicethe acoustic cardiographic parameters were calculated

    STIs were measured using simultaneous recording of the electrocardiogram and acoustic cardiography signals using an analogic numeric system (Biopac Systems, Goleta, CA). A3-minute acoustic cardiographic tracing for all patients was obtained and stored electronically. We measured the electromechanical activation time (EMAT) which is the time between the initial deflection of the electrocardiographic Q wave and the first phonocardiographic complex corresponding to the first heart sound (S1). The left ventricle ejection time (LVET) defined as the interval between the peak components from the S1 and S2 complexes was measured on the same cardiac cycles. All studies were performed in patients in a semi-recumbent position with head at 30 degrees position. For each patient, the acoustic cardiographic parameters were calculated from a 10-second free of artifact recording of data averaging 8 to 12 beats measurements.

06

What researchers measure

Primary outcomes

  1. PEP/EMAT values between the AHF and non AHF groups

    compare the PEP/EMAT values between the two study groups: AHF and non-AHF. the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.

    Time frame: at admission (an average of 24 hours)

Secondary outcomes

  1. PEP values between the two study groups

    compare the PEP values between the two study groups: AHF and non-AHF. the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.

    Time frame: at admission (an average of 24 hours)

  2. compare the EMAT values between the two study groups

    compare the EMAT values between the two study groups: AHF and non-AHF. the diagnosis of AHF is made based on clinical, BNP, and echocardiographic findings.

    Time frame: at admission (an average of 24 hours)

  3. compare the STI diagnostic performance against BNP

    compare the diagnostic performance, based on the area under curve estimation of the ROC curve, between the STI (PEP, EMAT and PEP/EMAT) and the BNP levels

    Time frame: at hospital admission (an average of 24 hours)

07

Study locations

1 site
  • Nouira Semir
    Monastir, Emergency Department Monastir, Tunisia 5000 5000, Tunisia
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02161445
Lead sponsor
University of Monastir
Responsible party
Pr. Semir Nouira (Professor, University of Monastir) — Principal investigator
First posted
Jun 11, 2014
Start date
Oct 2, 2012
Primary completion
Dec 31, 2017
Completion
Dec 31, 2019
Last update
Jul 1, 2020

Study contacts

Nouira Samir, Professor
principal investigator · University hospital of Monastir

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion